Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 June 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Predicting responses of patients with IBS to low-FODMAP diet and probiotics

This month's publication of Clinical Gastroenterology and Hepatology examines how volatile organic compounds in feces associate with response to dietary intervention in patients with irritable bowel syndrome.

News image

Dietary interventions are effective in management of patients with irritable bowel syndrome, although responses vary.

Dr Kevin Whelan and colleagues from the United Kingdom investigated whether fecal levels of volatile organic compounds associate with response to dietary interventions in patients with irritable bowel syndrome.

Adults who fulfilled the Rome III criteria for irritable bowel syndrome were recruited to a 2x2 factorial randomized controlled trial.

Patients were randomly assigned to a group counselled to follow a diet low in fructans, galacto-oligosaccharides, lactose, fructose, and polyols or a group that received placebo dietary advice for 4 weeks.

Patients from each group were also given either a multi-strain probiotic or placebo supplement.

Response was defined as a reduction of 50 points or more on the validated irritable bowel syndrome symptom scoring system.

The researchers collected fecal samples from participants at baseline and end of the 4-week study period, and volatile organic compounds were analyzed by a gas-chromatography sensor device.

The team determined volatile organic compounds profiles using a pipeline involving wavelet transformation followed by feature selection based on random forest.

Volatile organic compounds profiles contained 15 features that classified response to the low-FODMAP diet with a mean accuracy of 97%
Clinical Gastroenterology and Hepatology

A partial least squares classifier was constructed to classify volatile organic compounds profiles by response and accuracies were determined using 10-fold cross-validation.

Data from 93 patients who completed the study were used in the final analysis.

The team found more patients responded to the low-FODMAP diet than the sham diet, but there was no difference in response between patients given the probiotic vs the placebo, with no interaction between the diet and supplement interventions.

At baseline, volatile organic compounds profiles contained 15 features that classified response to the low-FODMAP diet with a mean accuracy of 97% and 10 features that classified response to probiotic with a mean accuracy of 89%.

End of treatment models achieved similar predictive powers and accuracies.

Dr Whelan's team comments, "Fecal volatile organic compounds profiling is a low cost, non-invasive tool that might be used to predict responses of patients with irritable bowel syndrome to low-FODMAP diet and probiotics and identify their mechanisms of action."

Clin Gastroenterol Hepatol 2018: 16(3): 385-391 e.1
22 March 2018

Go to top of page Email this page Email this page to a colleague

 31 May 2018 
Diagnostic for NAFLD  
 31 May 2018 
Bile acids and the risks for hepatotoxicity
 31 May 2018 
Rectal cancer female sexuality score
 30 May 2018 
Fungal dysbiosis in cirrhosis
 30 May 2018 
Placebo rates in ulcerative colitis trials
 30 May 2018 
Follow-up testing and colorectal cancer mortality
 29 May 2018 
Organ transplantation donors
 29 May 2018 
Novel therapies for IBD
 29 May 2018 
Helicobacter pylori infection to stomach cancer
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 28 May 2018 
Therapeutic strategies for HCV
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Chronic Hep B
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
European guidelines on pancreatic cystic neoplasms

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us